Google Übersetzer
Coherus Biosciences Inc
About
Coherus Biosciences Inc (NASDAQ:CHRS) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
Mar 2 2026
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
Feb 17 2026
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
Feb 13 2026
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
Feb 12 2026
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
Financials
Revenue
$42.17 M
Market Cap
$259.31 M
EPS
-1.56